ELISA Kit for Asymmetrical Dimethylarginine (ADMA)
CEB301GE
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Asymmetrical Dimethylarginine (ADMA)
- Delivery Days Customer12
- ApplicationsELISA
- Assay Detection Range12.35-1,000ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Asymmetrical Dimethylarginine (ADMA) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low,...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 4.99ng/mL
- Assay Test PrincipleThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Asymmetrical Dimethylarginine (ADMA) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin...
- Assay Time2h
- CertificationResearch Use Only
- UNSPSC41116100
References
- Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats-A Comparison with Mesna. Merwid-Lad A et al., 2021 Nov 29, Pharmaceuticals (Basel)Read this paper
- Non-functioning adrenal incidentalomas may increase toxic metabolites. Karahan I et al., 2022 Feb, Wien Klin WochenschrRead this paper
- Levels of endothelial substances in patients with newly identified hypertension compared with healthy controls. Biel V et al., 2021 Nov, Biomed Pap Med Fac Univ Palacky Olomouc Czech RepubRead this paper
- Multivessel analysis of progressive vascular aging in the rat: Asynchronous vulnerability among vascular territories. El Assar M et al., 2018 Jul, Mech Ageing DevRead this paper
- A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling. Shahin NN et al., 2018 Mar 9, Sci RepRead this paper
- Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Reddy KRK et al., 2018 Feb, AngiogenesisRead this paper
- Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease. Xuan C et al., 2017 Jan, Clin Chim ActaRead this paper
- Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study. Xuan C et al., 2016 Sep 28, Sci RepRead this paper
- Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. El Assar M et al., 2016 Jun 1, J PhysiolRead this paper
- Dimethylarginine dimethylaminohydrolase-1 mediates inhibitory effect of interleukin-10 on angiotensin II-induced hypertensive effects in vascular smooth muscle cells of spontaneously hypertensive rats. Kim HY et al., 2016 Jan, CytokineRead this paper
Related products
Product group Assays
Assay Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
ReactivityOther Species
- SizePrice
Product group Assays
ReactivityHuman
- SizePrice
Product group Assays
Assay Sample TypeSerum, Plasma
ReactivityHuman
- SizePrice
Product group Assays
Assay Sample TypeSerum, plasma, tissue homogenates and other biological fluids
ReactivityHuman
- SizePrice